Results 231 to 240 of about 1,521,198 (298)
Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
ABSTRACT Alopecia areata (AA) is an autoimmune disease characterized by non‐scarring hair loss of the scalp and/or body, with an unpredictable and variable clinical course. Its etiology is not entirely understood, although evidence suggests that environmental, immunological, and genetic factors contribute to disease development.
Marco Rubatto +7 more
wiley +1 more source
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli +5 more
wiley +1 more source
Nonneural granular cell tumor treated with Mohs micrographic surgery
Frank Z. Jing, MD +4 more
doaj +1 more source
DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau +11 more
wiley +1 more source
Nail Disorders in Systemic Conditions
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley +1 more source
A Curious Case of Patterned Scarring Alopecia
JEADV Clinical Practice, EarlyView.
Jeta Buch +3 more
wiley +1 more source

